NCT00003755View on ClinicalTrials.gov

Ro 31-7453 in Treating Patients With Locally Advanced or Metastatic Solid Tumor

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

August 31, 2001

Study Completion Date

August 31, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

MKC-1

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER